Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

IPCA LABORATORIES LTD. - 524494 - Income Tax Survey

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023. The Company has extended its full co-operation and support to the Officials of the Income Tax Department during their survey proceedings and has provided timely and correct information/data asked for and shall continue to provide any further details/information that might be required by the department in future.
03-06-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copies of the Newspaper publication of Audited Financial Results for the 4th quarter and financial year ended 31st March, 2023 published on 30th May, 2023 in Financial Express (all India editions), Nav Shakti (in Marathi) and Free Press.
02-06-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Please note that the Q4FY23 results conference call of Ipca Laboratories Ltd. has been cancelled due to unavoidable circumstances. The new date for the call will be communicated shortly.
30-05-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023.

 Disclosure of related party transactions for the half year ended March 31, 2023.
29-05-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 We are enclosing herewith a certified copy of the Annual Secretarial Compliance Report for the period ended March 31, 2023
29-05-2023

IPCA Laboratories Q4 results: Net profit declines 41% to Rs 76.52 crore

 The company's consolidated revenue from operation rose by 17.3 per cent to Rs 1,512 crore for the March quarter
29-05-2023
Bigul

Q4FY23 Quarterly & FY23 Annual Result Announced for Ipca Laboratories Ltd.

 Pharmaceuticals company Ipca Laboratories announced Q4FY23 & FY23 results: Q4FY23: Standalone Net total Income up 21% at Rs 1,435.10 crore Consolidated Net total Income up 19% at Rs 1,548.02 crore Indian formulations income is up 10% at Rs 607.94 crore Exports Income up 30% at Rs 684.86 crore Standalone EBITDA margin (before forex (gain)/loss) @13.81% in Q4FY23 as against @16.43% in Q4FY22 Consolidated EBITDA margin @ 13.37% in Q4 FY23 as against @18.11% in Q4 FY22 Standalone Net Profit at Rs 84.82 crore down 23% Consolidated Net Profit at Rs 76.52 crore down 41%. FY23: Standalone Net Total Income up 8% at Rs 5,925.81 crore Consolidated Net Total Income up 8% at Rs 6,369.94 crore Indian formulations income is up 10% at Rs 2,760.71 crore Exports Income up 5% at Rs 2,643.42 crore Standalone EBITDA margin (before forex (gain) / loss) @17.79% in FY23 as against @22.94% in FY22 Consolidated EBITDA margin @17.01% in FY23 as against @22.81% in FY22 Standalone Net Profit at Rs 505.70 crore down 41% Consolidated Net Profit at Rs 471.32 crore down 47% Result PDF
29-05-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Audited Financial Results, Standalone And Consolidated For The 4Th Quarter And Financial Year Ended 31St March, 2023

 We are enclosing herewith Audited Financial Results, Standalone and Consolidated for the 4th quarter and financial year ended 31st March, 2023 which were taken on record at the Meeting of the Board of Directors of the Company held today at Mumbai.
29-05-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Audited Financial Results, Standalone And Consolidated For The 4Th Quarter And Financial Year Ended 31St March, 2023

 We are enclosing herewith Audited Financial Results, Standalone and Consolidated for the 4th quarter and financial year ended 31st March, 2023 which were taken on record at the Meeting of the Board of Directors of the Company held today at Mumbai.
29-05-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform you that a Conference Call to discuss the Company's Q4 FY23 earnings and business update will be held on Tuesday, 30th May, 2023 at 15.30 hrs IST.
24-05-2023
Next Page
Close

Let's Open Free Demat Account